[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of Common Stock scheduled on 08/21/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. Two separate lots are listed: 796 shares with an aggregate market value of $125,119.26 and 11,128 shares with an aggregate market value of $1,749,154.68, for a combined market value of $1,874,273.94. The securities were acquired on 08/18/2025 as Performance Stock Program Awards from The Procter & Gamble Company; amounts acquired were 1,725 and 24,091 shares respectively, with payment dates on 08/18/2025. The filer reports no securities sold in the past three months and includes the standard signature representations required by Rule 144.

Positive

• Compliance disclosure filed under Rule 144 with detailed acquisition and broker information
• No sales reported in the prior three months, simplifying aggregation and compliance review
• Securities acquired via Performance Stock Program and listed with acquisition/payment dates, improving transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; size appears immaterial to PG's market capitalization.

The filing documents a Rule 144 notice for proposed sales totaling about $1.87 million executed via Morgan Stanley Smith Barney on 08/21/2025. The shares were granted under a performance stock program two days earlier and the filer reports no sales in the prior three months. For a large-cap issuer like PG, this filing represents a routine compliance disclosure rather than a material market-moving event.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements and includes required signer representation.

The notice provides acquisition details (dates, grant type, grantor) and broker information, fulfilling transparency expectations for potential insider sales. The statement that no undisclosed material adverse information is known and the absence of recent prior disposals simplify governance review. There is no indication of unusual trading plans or irregularities in the filing text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	796	125119.26	2342371488	08/21/2025	NYSE
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	11128	1749154.68	2342371488	08/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			1725	08/18/2025	NA
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			24091	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for PG on 08/21/2025 disclose?

It discloses proposed sales of Common Stock totaling $1,874,273.94 (796 shares: $125,119.26; 11,128 shares: $1,749,154.68) through Morgan Stanley Smith Barney LLC on 08/21/2025.

When were the shares being sold originally acquired for PG's Form 144?

The shares were acquired on 08/18/2025 as Performance Stock Program Awards from The Procter & Gamble Company.

Does the filing report any sales of PG securities in the prior three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is handling the proposed sale in the PG Form 144?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY, executing on the NYSE.

Are there any indications of undisclosed material information in the filing?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.